Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Chieti
Clinical trial register · Italy

Clinical Trials in Chieti, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
G. d'Annunzio University8 Hoffmann-La Roche7 Amgen6 Novo Nordisk A/S6 Sanofi4
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Chieti

82 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Chieti, Bari, Castellana Grotte (BA), Catanzaro, Cosenza, Naples, Salerno, Ferrara
2026-10-26
Not yet open
G. d'Annunzio University
Not applicable
40
Chieti
2026-09-01
Recruiting
Novo Nordisk A/S
Phase 3
1,778
Chieti, Catanzaro, Naples, Ravenna, Chiavari, Milan, Roma, Lucca
2026-08-24
Recruiting
Guerbet
Phase 3
315
Bergamo, Cagliari, Chieti, Milan, Roma, Treviso
2026-07-28
Recruiting
AstraZeneca
Phase 3
1,200
Bari, Bologna, Chieti, Milan, Modena, Naples, Roma
2026-07-06
Recruiting
AstraZeneca
Phase 3
4,500
Bologna, Catania, Chieti, Florence, Latina, Milan, Pisa, Ravenna
2026-06-29
Recruiting
ICIM International S.r.l.
Not applicable
21
Chieti
2026-05-12
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Chieti, Cosenza, Naples, Bentivoglio, Bologna, Ferrara, Reggio Emilia, Udine
2026-05-11
Not yet open
G. d'Annunzio University
Observational
100
Chieti
2026-05-01
Recruiting
ICIM International S.r.l.
Not applicable
35
Chieti
2026-04-30
Recruiting
G. d'Annunzio University
Not applicable
36
Chieti
2026-04-20
Recruiting
Università degli Studi 'G. d'Annunzio' Chieti e Pescara
Observational
60
Chieti
2026-03-24
Recruiting
Zenas BioPharma (USA), LLC
Phase 3
705
Pozzilli, Chieti
2026-03-23
Recruiting
Hoffmann-La Roche
Phase 2
360
Chieti, Naples, Salerno, Roma, Genoa, Milan, Pavia
2026-03-10
Recruiting
Sanofi
Phase 2
144
Torette, Cona, Garbagnate Milanese, Milan, Brescia, Chieti, Pisa
2025-12-29
Recruiting
Dompé Farmaceutici S.p.A
Phase 3
153
Bologna, Chieti, Florence, Roma, Verona
2025-12-01
Recruiting
G. d'Annunzio University
Not applicable
44
Chieti
2025-11-27
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
L’Aquila, Cagliari, Rozzano, Baggiovara, Bologna, Chieti, Naples, Roma
2025-09-22
Recruiting
AstraZeneca
Phase 3
700
Arezzo, Bari, Bergamo, Chieti, Genoa, Milan, Naples, Palermo
2025-08-06
Recruiting
Amgen
Phase 3
12,800
Arzignano, Caserta, Ceccano, Chieti, Foggia, L’Aquila, Milan, Padova
2025-07-25
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Acquaviva Delle Fonti (BA), Bergamo, Brescia, Catania, Catanzaro, Chieti, Cona (FE), Coppito (AQ)
2025-07-22
Active, closed
REal-life ON PARKinson's - ITaly (REONPARK-IT)
NCT07403799Parkinson Disease
Bial - Portela C S.A.
Observational
200
Bari, Brescia, Cagliari, Catanzaro, Chieti, Genova, Messina, Milan
2025-07-08
By invitation
MoonLake Immunotherapeutics AG
Phase 3
835
Catania, Chieti, Cona, Florence, Milan, Modena, Naples, Perugia
2025-06-27
Recruiting
Peritoneal Ultrafiltration in Cardio Renal Syndrome.
NCT03994874Congestive Heart Failure
Iperboreal Pharma Srl
Phase 1/2
84
Chieti, Milan, Naples
2025-04-16
Not yet open
Certmedica International GmbH
Not applicable
240
Pisa, Chieti, Perugia
2025-04-01
Active, closed
Amgen
Phase 3
1,105
Bologna, Chieti, Florence, Milan, Palermo
2025-03-17
Active, closed
Amgen
Phase 3
3,853
Bologna, Chieti, Florence, Milan, Palermo, Pisa, Roma
2025-03-12
Recruiting
Incyte Corporation
Phase 3
600
Bari, Brescia, Catania, Chieti, Florence, L’Aquila, Milan, Naples
2025-02-28
Active, closed
Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY
NCT05485831Lennox Gastaut Syndrome, Dravet Syndrome, Tuberous Sclerosis Complex
DrugCannabidiol
Jazz Pharmaceuticals
Observational
111
Bologna, Catanzaro, Chieti, Florence, Genova, Messina, Milan, Naples
2025-02-24
By invitation
Learning Curves of Different Devices for Vaginal Birth on Mannequin
NCT06923319Forceps Delivery Affecting Fetus or Newborn, Ventouse Extraction;Liveborn, Birth; Forced
G. d'Annunzio University
Observational
30
Chieti, Pescara
2025-02-01
Not yet open
Point-of-care Low-field MRI in Acute Stroke
NCT05816213Stroke, Ischemic Stroke, Hemorrhagic Stroke, Magnetic Resonance Imaging
University of L'Aquila
Observational
300
Avezzano, Chieti, L’Aquila, Milan
2025-02-01
Active, closed
AI-Powered ECG Detecting Culprit Vessel Blood Flow Abnormality in ACS
NCT06528821Acute Coronary Syndrome, STEMI, Coronary Occlusion, Coronary Syndrome
Powerful Medical
Observational
800
Chieti, Rome
2024-12-10
Recruiting
Novo Nordisk A/S
Phase 2
465
L’Aquila, Chieti, Bologna, Bergamo, Brescia, Milan, Pisa, Roma
2024-12-02
Not yet open
G. d'Annunzio University
Not applicable
40
Chieti
2024-12-01
Not yet open
Optimizing Clinical Outcomes in CAF + SCTG: the Impact of Compressive Sutures
NCT06701786Gingival Recessions, Gingival Recession, Mucogingival Surgery, Suture
G. d'Annunzio University
Not applicable
40
Chieti
2024-12-01
Not yet open
G. d'Annunzio University
Not applicable
40
Chieti
2024-11-30
Active, closed
Amgen
Phase 2
409
Bari, Bologna, Chieti, Milan
2024-11-07
Not yet open
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
200
Chieti, Milan, Messina, Roma
2024-11-01
Active, closed
Incyte Corporation
Phase 3
349
Catania, Chieti, L’Aquila, Milan, Naples, Perugia, Pisa, Rome
2024-10-10
Recruiting
Prevention ICONA Dedicated Ensemble
NCT07186244PrEP, PrEP Adherence Monitoring, HIV, HIV -1 Infection
Fondazione ICONA
Observational
5,000
Chieti, Pescara, Bari, Foggia, Potenza, Caserta, Naples, Bologna
2024-09-09
Active, closed
Boehringer Ingelheim
Phase 3
11,000
Alessandria, Asti, Bari, Bergamo, Bologna, Cagliari, Chieri, Chieti
2024-08-30
Active, closed
Novartis Pharmaceuticals
Observational
379
Ancona, L’Aquila, Bari, Bergamo, Chieti, Catania, Catanzaro, Cona
2024-07-30
By invitation
Biohaven Therapeutics Ltd.
Phase 2
660
Chieti, Catanzaro, Naples, Bologna, Rome, Genoa, Milan, Pavia
2024-07-30
Recruiting
Janssen Research & Development, LLC
Phase 3
752
Brescia, Catania, Chieti, Genova, Monza, Pisa, Roma, Salerno
2024-07-25
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Chieti, Caserta, Cona (Ferrara), Latina, Bergamo, San Donato Milanese, Turin, Pordenone
2024-06-25
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Chieti, Catanzaro, Naples, Bologna, Rome, Genoa, Milan, Pavia
2024-05-13
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
DrugTeriflunomide
Sanofi
Phase 3
2,500
Pozzilli, Milan, Rome, Florence, Bergamo, Cagliari, Catania, Chieti
2024-04-16
Active, closed
Sanofi
Phase 3
464
Turin, Chieti, Modena, Naples, Perugia
2024-02-29
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
DrugTrastuzumab deruxtecan
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Alessandria, Chieti, Città di Castello, Empoli, Lecce, Lecco, Legnago, Legnano
2023-10-24
By invitation
An Open-label Study of XEN1101 in Epilepsy
NCT05718817Focal Epilepsy, Tonic-Clonic Seizures
DrugAzetukalner
Xenon Pharmaceuticals Inc.
Phase 3
880
Bologna, Chieti, Pisa, Roma
2023-04-25
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Ancona, Brescia, Caserta, Chieti, Catanzaro, Florence, Chiavari, Genova
2023-03-09
Active, closed
Novo Nordisk A/S
Phase 3
7,101
Chieti, Bari, Modena, Parma, Rome, San Donato Milanese (MI), Latina, Pavia
2023-03-01
Recruiting
ITAB - Institute for Advanced Biomedical Technologies
Not applicable
80
Chieti
2023-02-28
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
160
Ancona, Chieti, Pisa, Roma
2023-02-14
Recruiting
Iperboreal Pharma Srl
Phase 3
170
Ascoli Piceno, Bagno a Ripoli, Bari, Brescia, Chieti, Genova, L’Aquila, Milan
2022-12-14
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
DrugsVabysmo·Faricimab
Hoffmann-La Roche
Observational
6,000
Chieti, Bari, Catanzaro, Naples, Udine, Rome, Genoa, Bergamo
2022-11-21
Recruiting
Esketamine Nasal Spray in Real-World Settings in Treatment-Resistant Depression
NCT07146503Depression and Quality of Life, Treatment Resistant Depression (TRD), Anhedonia, Apathy
DrugsIntranasal·Esketamine
Riccardo Guglielmo
Observational
100
Genova, Chieti, Milan, Pavia
2022-11-01
Active, closed
Sanofi
Phase 2/3
1,856
Milan, Rozzano, Naples, Rome, Turin, Bologna, Catania, Chieti
2022-08-22
Active, closed
Daiichi Sankyo
Phase 3
586
Bari, Chieti, Lucca, Milan, Orbassano, Parma, Perugia, Roma
2022-07-08
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 2/3
12
Chieti, Gallarate, Roma
2022-06-23
Active, closed
Hoffmann-La Roche
Phase 3
188
Chieti, Bari, Rome, Milan, Catania
2022-05-19
Recruiting
Amgen
Phase 3
60
Chieti, Genova, Milan, Roma
2022-03-17
Active, closed
Daiichi Sankyo
Phase 3
740
Bari, Chieti, Lucca, Milan, Naples, Perugia, Rome, Varese
2022-03-04
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
800
Chieti, Potenza, Caserta, Catanzaro, Cosenza, Bologna, Genova, Bergamo
2022-01-26
Active, closed
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
NCT05407636AMD, nAMD, Wet Age-related Macular Degeneration, wAMD
DrugsEylea·Aflibercept
AbbVie
Phase 3
735
Cona, Milan, Naples, Rome, Negrar, Bari, Chieti, Udine
2022-01-13
Recruiting
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 3
162
Meldola, Alessandria, Bari, Catania, Chieti, Ferrara, Genova, Mestre
2021-12-14
Recruiting
Niguarda Hospital
Phase 3
288
Ancona, Bergamo, Bologna, Brescia, Cagliari, Chieti, Florence, Genova
2021-10-07
Recruiting
Amgen
Phase 3
60
Chieti, Genova, Milan, Roma
2021-09-09
Active, closed
Hoffmann-La Roche
Phase 3
451
Chieti, Bari, Trieste, Rome, Milan, Torrette - Ancona, Florence, Perugia
2021-07-14
Active, closed
Hoffmann-La Roche
Phase 3
751
Chieti, Bari, Naples, Rome, Genoa, Milan, Montichiari, Pavia
2021-03-24
Active, closed
Galderma R&D
Phase 3
500
Catania, Chieti, Genova, L’Aquila, Modena, Naples, Parma, Perugia
2021-01-11
Active, closed
Hoffmann-La Roche
Phase 3
864
Chieti, Naples, Rome, Milan, Pozzilli
2020-11-26
Recruiting
AutoInflammatory Disease Alliance Registry (AIDA)
NCT05200715Hereditary Autoinflammatory Diseases, Schnitzler Syndrome, Behcet Syndrome, PFAPA Syndrome
University of Siena
Observational
3,500
Siena, Bari, Bolzano, Brescia, Cagliari, Catania, Catanzaro, Chieti
2020-08-06
Active, closed
Eli Lilly and Company
Phase 3
58
Brescia, Chieti, Genova, Milan, Naples, Palermo, Trieste
2020-02-12
Active, closed
Consorzio Oncotech
Observational
600
Aviano, Bari, Bergamo, Brindisi, Chieti, Como, Cuneo, Florence
2019-10-24
Active, closed
NeuroDerm Ltd.
Phase 3
381
Arcugnano, Cassino, Chieti, Grosseto, Milan, Naples, Pavia, Roma
2019-09-30
Active, closed
Janssen Research & Development, LLC
Phase 3
2,517
Abano Terme, Acquaviva delle Fonti, Bassano del Grappa, Brescia, Chieti, Florence, Milan, Modena
2019-06-11
Recruiting
Eli Lilly and Company
Phase 3
190
Brescia, Chieti, Genova, Milan, Naples, Palermo, Trieste
2019-04-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,397
Chieti, Milan, Turin, Bolzano, Florence, Arezzo, Bari, Genova
2018-12-24
Recruiting
Hoffmann-La Roche
Phase 3
1,000
Chieti, Bari, Trieste, Rome, Milan, Torrette - Ancona, Florence, Perugia
2018-09-20
Active, closed
pharmaand GmbH
Phase 3
1,097
Aviano, Candiolo, Catania, Chieti, Naples, Roma, Vicenza
2018-05-14
Active, closed
NeuroDerm Ltd.
Phase 2
214
Chieti, Pisa, Rome, Venice
2016-05-04
Rows per page Showing 1–82 of 82
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-italy/city/chieti

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 82 of those studies with a site in Chieti.

How many clinical trials are recruiting in Chieti?

36 of the 82 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 9 have not yet opened recruitment, 33 are active but closed to new participants, and 4 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Chieti), 82 studies
PhaseStudiesRecruitingShare
Phase 3462156.1%
Observational16619.5%
Not applicable10512.2%
Phase 2637.3%
Phase 2/3303.7%
Phase 1/2111.2%

Most active sponsors

Lead sponsors with the most studies (Chieti)
Lead sponsorStudiesRecruiting
G. d'Annunzio University82
Hoffmann-La Roche72
Amgen63
Novo Nordisk A/S63
Sanofi41
AstraZeneca33
Biohaven Therapeutics Ltd.20
Boehringer Ingelheim21
Daiichi Sankyo20
Eli Lilly and Company21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.